Buyer for generic API CDMO company in Europe

Company to buy

Size: Mid-sized business
Revenue: 3 -30 million EUR
Target location: Europe
CFIE PHB262

Overview of buyer for generic API CDMO company in Europe

The company is a global, science-led pharmaceutical organization with over five decades of experience. In particular, in the pharmaceutical, chemical, and healthcare industries. Currently, it seeks to expand its presence through the acquisition of a generic API CDMO in Europe.

At this time, the organization has established itself as a significant player in the global pharmaceutical and healthcare arena. Over several decades, it has developed a strong reputation for its expertise in the development, scale-up, and commercialization of pharmaceutical products. Chiefly, the company’s focus is on becoming the integrated growth partner of choice for businesses worldwide.

Profile of buyer for generic API CDMO company in Europe

With a longstanding commitment to quality, integrity, leadership, respect, and sustainability, this organization has built extensive relationships with customers globally. Crucially, its capabilities in process chemistry, engineering, and manufacturing have enabled it to evolve as a strategic partner. Especially, involving collaboration, development, and manufacturing advanced pharmaceutical intermediates and APIs.

Activity and products of buyer for generic API CDMO company in Europe

Overall, the company is recognized as a key player in the production of artificial sweeteners, particularly saccharin, and contrast media intermediates. Further, it has also expanded its operations to include contract development and manufacturing, focusing on niche advanced intermediates and APIs. Essentially, the company applies cutting-edge processes to products at all phases. Thus, ensuring a robust and customized approach to meet customer needs.

Highlights of buyer for generic API CDMO company in Europe

Experience: Over 50 years of industry expertise
Global reach: Operations in more than 50 countries, serving 140+ customers
Manufacturing facilities: Four state-of-the-art facilities dedicated to innovation and quality
Sustainability commitment: Aligned with the United Nations’ Sustainability Goals, the company is dedicated to green chemistry, pollution minimization, and carbon emission reduction

Altogether, this organization’s strategic growth plan includes new projects, products, and technologies, Moreover, it includes making strategic acquisitions and investments, particularly in the European market.

More information on this buyer for generic API CDMO company in Europe

Please get in touch if you are interested in learning more about this buyer for generic API CDMO company in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.